$1.82 0.02 (+1.11%)
2/13/2012 12:43 PM

ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Featured Broker Partners


Advertisement